FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 20:39:55 25/06/2024 BST | ||
| 4.24 EUR | -5.99% |
|
| Current month | -23.19% | ||
| 1 month | -21.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 4.24 | -5.99% |
| 24/06/24 | 4.51 | -10.16% |
| 21/06/24 | 5.02 | -1.95% |
| 20/06/24 | 5.12 | -4.48% |
| 19/06/24 | 5.36 | -0.92% |
Real-time Boerse Frankfurt Warrants
Last update June 25, 2024 at 08:39 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SU6TUJ |
| ISIN | DE000SU6TUJ9 |
| Date issued | 11/01/2024 |
| Strike | 307.2 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.42 € |
|---|---|
| Lowest since issue | 3.97 € |
| Spread | 0.03 € |
| Spread % | 0.70% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
